articleAnnals of SurgeryJul 19, 2006GREEN OA

Epidemiology and Management of Liver Metastases From Colorectal Cancer

Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers

PubMed
Indexed incrossrefpubmed

Abstract

Methods

Data were obtained from the population-based cancer registry of Burgundy (France).

Results

The proportion of patients with synchronous liver metastases was 14.5%. Age-standardized incidence rates were 7.6 per 100,000 in males, 3.7 per 100,000 in females. The 5-year cumulative metachronous liver metastasis rate was 14.5%. It was 3.7% for TNM stage I tumors, 13.3% for stage II, and 30.4% for stage III (P

No related works found for this paper.